Breaking News Instant updates and real-time market news.

HIIQ

Health Insurance Innovations

$23.35

-6.55 (-21.91%)

10:41
09/12/17
09/12
10:41
09/12/17
10:41

Health Insurance Innovations regulatory items will get resolved, says Canaccord

Canaccord analyst Richard Close believes Health Insurance Innovations' outstanding regulatory issues will be resolved without a meaningful impact on the business, but said it could take time and remain an overhang until this is settled. Close maintains a Buy rating and said the next likely catalysts for shares would be a resolution to the Florida third-party administrator license application situation.

  • 13

    Sep

  • 22

    Sep

HIIQ Health Insurance Innovations
$23.35

-6.55 (-21.91%)

08/04/17
ADAM
08/04/17
NO CHANGE
Target $39
ADAM
Buy
Health Insurance Innovations price target raised to $39 from $30 at Canaccord
Canaccord analyst Richard Close raised his price target on Health Insurance Innovations to $39 from $30 and recommends investors either add to or initiate positions. The company has demonstrated strong growth is possible in the current environment and he expects it to continue. Close reiterated his Buy rating on Health Insurance Innovations shares.
09/01/17
ADAM
09/01/17
NO CHANGE
Target $39
ADAM
Buy
Health Insurance Innovations pullback a buying opportunity, says Canaccord
Canaccord analyst Richard Close attributes the sharp pullback in Health Insurance Innovations yesterday that has continued into this morning to a New York Times article quoting a White House official as saying the administration wants to stabilize the ACA insurance market. This was followed by several media reports that the government would be cutting funding for ACA advertising by 90% and funding for the navigator program by 40%, Close added. While less advertising and funding to promote the ACA could mean fewer people will seek lower-cost alternatives, a negative for Health Insurance Innovations, he thinks this news could actually be positive for the company since less advertising also implies a potentially lower cost per lead/conversion and he still expects solid demand for its offerings. Close, who recommends buying the stock on the pullback, keeps a Buy rating and $39 price target on Health Insurance Innovations shares.
09/05/17
ADAM
09/05/17
NO CHANGE
Target $39
ADAM
Buy
Health Insurance Innovations weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Close said the recent pullback in Health Insurance Innovations had provided a good entry point and he recommends buying the weakness. The analyst sees a less stabilized ACA market as a positive for the company, as higher premium rates and fewer options give people a reason to look at lower-cost alternatives from Health Insurance Innovations. Close reiterated his Buy rating and $39 price target on the shares.
09/11/17
CANT
09/11/17
NO CHANGE
Target $38
CANT
Overweight
Health Insurance Innovations weakness 'mostly unfounded,' says Cantor
Cantor Fitzgerald analyst Steven Halper said he views the weakness in Health Insurance Innovations following a short report issued on the stock as "mostly unfounded." One of the central focuses of the report is the ongoing 42-state investigation into operating practices that was previously disclosed and he sees the claim of a potential $100M in penalties as unfounded. He has spoken to the company and noted that management intends to host an investor/analyst call later today, he tells investors. Halper has an Overweight rating and $38 price target on Health Insurance Innovations shares, which are off their lows but remain down over 25% in afternoon trading.

TODAY'S FREE FLY STORIES

KRA

Kraton

$25.50

-0.77 (-2.93%)

06:26
01/24/19
01/24
06:26
01/24/19
06:26
Recommendations
Kraton analyst commentary  »

Kraton shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCMLY

LafargeHolcim

$0.00

(0.00%)

06:25
01/24/19
01/24
06:25
01/24/19
06:25
Downgrade
LafargeHolcim rating change  »

LafargeHolcim downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESSYY

Essity

$0.00

(0.00%)

06:23
01/24/19
01/24
06:23
01/24/19
06:23
Initiation
Essity initiated  »

Essity initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$8.03

0.3 (3.88%)

06:23
01/24/19
01/24
06:23
01/24/19
06:23
Periodicals
PG&E says wildfire prevention may cost up to $150B, Reuters reports »

PG&E, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONXXF

Ontex Group

$0.00

(0.00%)

06:21
01/24/19
01/24
06:21
01/24/19
06:21
Initiation
Ontex Group initiated  »

Ontex Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

, GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

06:20
01/24/19
01/24
06:20
01/24/19
06:20
Periodicals
Google to appeal $57M fine for breaching GDPR rules, Business Insider reports »

Google has confirmed it…

GOOG

Alphabet

$1,076.04

5.32 (0.50%)

GOOGL

Alphabet Class A

$1,085.27

6.59 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

AAPL

Apple

$153.91

0.61 (0.40%)

, SSNLF

Samsung

$0.00

(0.00%)

06:18
01/24/19
01/24
06:18
01/24/19
06:18
Periodicals
Samsung exec poached by Apple to lead battery development, Bloomberg reports »

Apple (AAPL) has poached…

AAPL

Apple

$153.91

0.61 (0.40%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

EADSY

Airbus

$0.00

(0.00%)

06:14
01/24/19
01/24
06:14
01/24/19
06:14
Periodicals
Airbus CEO issues warning about jobs in event of no-deal Brexit, Reuters reports »

Airbus CEO Tom Enders…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$30.55

1 (3.38%)

06:11
01/24/19
01/24
06:11
01/24/19
06:11
Periodicals
Sinclair Broadcast hires liberal commentator Ameshia Cross, WSJ reports »

Sinclair Broadcast, known…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$91.51

-0.13 (-0.14%)

06:10
01/24/19
01/24
06:10
01/24/19
06:10
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$15.22

-0.18 (-1.17%)

06:08
01/24/19
01/24
06:08
01/24/19
06:08
Downgrade
CenturyLink rating change  »

CenturyLink downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 25

    Feb

ASND

Ascendis Pharma

$73.16

-0.47 (-0.64%)

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Upgrade
Ascendis Pharma rating change  »

Ascendis Pharma upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIV

F5 Networks

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Recommendations
F5 Networks analyst commentary  »

F5 Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTH

Duluth Holdings

$20.41

0.425 (2.13%)

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Upgrade
Duluth Holdings rating change  »

Duluth Holdings upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:06
01/24/19
01/24
06:06
01/24/19
06:06
Hot Stocks
Nissan plans April investor meeting to oust Ghosn from board »

Nissan (NSANY) announced…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.27

-0.07 (-0.52%)

, BDRBF

Bombardier

$0.00

(0.00%)

06:05
01/24/19
01/24
06:05
01/24/19
06:05
Hot Stocks
Bombardier to acquire Global 7500 aircraft wing program from Triumph Group »

Bombardier (BDRBF)…

TGI

Triumph Group

$13.27

-0.07 (-0.52%)

BDRBF

Bombardier

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

RNSDF

Renault

$0.00

(0.00%)

06:05
01/24/19
01/24
06:05
01/24/19
06:05
Periodicals
Renault's board asked to name Senard, Bollare to replace Ghosn, Reuters says »

Renault's board will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.04

0.195 (2.20%)

06:03
01/24/19
01/24
06:03
01/24/19
06:03
Periodicals
Deutsche Bank gets inquiry from House panels on Trump ties, Reuters reports »

Deutsche Bank has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$99.46

-1.16 (-1.15%)

06:03
01/24/19
01/24
06:03
01/24/19
06:03
Downgrade
Post Holdings rating change  »

Post Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 01

    Feb

MTL

Mechel

$2.50

0.075 (3.10%)

06:01
01/24/19
01/24
06:01
01/24/19
06:01
Hot Stocks
Mechel launches steel trade online store »

Mechel reports launching…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

06:01
01/24/19
01/24
06:01
01/24/19
06:01
Periodicals
Carlos Ghosn resigns as head of Renault, Bloomberg reports »

Carlos Ghosn has resigned…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URGN

UroGen Pharma

$45.90

-7.6 (-14.21%)

06:00
01/24/19
01/24
06:00
01/24/19
06:00
Syndicate
UroGen Pharma 3.66M share Secondary priced at $41.00 »

Goldman Sachs, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

GRBK

Green Brick

$8.13

0.13 (1.63%)

06:00
01/24/19
01/24
06:00
01/24/19
06:00
Initiation
Green Brick initiated  »

Green Brick initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$51.39

6.01 (13.24%)

05:59
01/24/19
01/24
05:59
01/24/19
05:59
Syndicate
eHealth 2.4M share Secondary priced at $48.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

INCY

Incyte

$75.20

-2.11 (-2.73%)

05:59
01/24/19
01/24
05:59
01/24/19
05:59
Upgrade
Incyte rating change  »

Incyte upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.